[{"AccountsPayableCurrent_0_Q2_USD":1186000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":71000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":60000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1835000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_2_Q2_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q2_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":49000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-5000.0,"OtherAssetsCurrent_0_Q2_USD":357000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.054,"OperatingLeaseRightOfUseAsset_0_Q2_USD":356000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":322000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":34000.0,"OperatingLeaseCost_1_Q2_USD":15000.0,"OperatingIncomeLoss_2_Q2_USD":8652000.0,"OperatingIncomeLoss_1_Q2_USD":4765000.0,"OperatingExpenses_2_Q2_USD":6080000.0,"OperatingExpenses_1_Q2_USD":3020000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":10225000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-222000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-1985000.0,"LiabilitiesCurrent_0_Q2_USD":4431000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":116794000.0,"Liabilities_0_Q2_USD":9429000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":108000.0,"PaymentsOfDividends_2_Q2_USD":2077000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":222000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":3656000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":3655000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":11000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":9000.0,"StockOptionPlanExpense_1_Q2_USD":41000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":3000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":107365000.0,"StockholdersEquity_0_Q2_USD":107365000.0,"ShareBasedCompensation_2_Q2_USD":82000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":5821000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":2892000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q2_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":23568000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":12604000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":115326000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":259000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":128000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":8000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":10812000.0,"ProfitLoss_2_Q2_USD":6450000.0,"ProfitLoss_1_Q2_USD":3426000.0,"ProductWarrantyAccrual_0_Q2_USD":0.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":92000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":464000.0,"InventoryWorkInProcess_0_Q2_USD":1263000.0,"InventoryRawMaterials_0_Q2_USD":3767000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":486000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":22000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":8836000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":4819000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":6445000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":3475000.0,"CommonStockValue_0_Q2_USD":36000.0,"CommonStockSharesOutstanding_0_Q2_shares":3646000.0,"CommonStockSharesIssued_0_Q2_shares":3646000.0,"CommonStockSharesAuthorized_0_Q2_shares":50000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":7916000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":59506000.0,"AssetsCurrent_0_Q2_USD":70587000.0,"Assets_0_Q2_USD":116794000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":82000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":41000.0,"AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2_Q2_USD":3775000.0,"AdjustmentForAmortization_2_Q2_USD":3335000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":289000.0,"AccumulatedOtherComprehensiveIncomeLossBeforeTax1_0_Q2_USD":-8286000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":3245000.0,"AccountsReceivableNetCurrent_0_Q2_USD":4606000.0,"DeferredTaxExpenseFromStockOptionsExercised_2_Q2_USD":5000.0,"DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_0_Q2_USD":2355000.0,"Depreciation_2_Q2_USD":325000.0,"DividendsCommonStockCash_1_Q2_USD":1037000.0,"InventoryNet_0_Q2_USD":6118000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":1088000.0,"InterestPaid_2_Q2_USD":0.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":20803000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":14000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-75000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":34000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":517000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":399000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":2273000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":1399000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":3645000.0,"IncomeTaxesPaid_2_Q2_USD":2279000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":4825000.0,"GrossProfit_2_Q2_USD":14732000.0,"GrossProfit_1_Q2_USD":7785000.0,"Goodwill_0_Q2_USD":14236000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":56510000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":35707000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-102000.0,"EarningsPerShareDiluted_1_Q2_USD":0.94,"EarningsPerShareDiluted_2_Q2_USD":1.76,"EarningsPerShareBasic_1_Q2_USD":0.94,"EarningsPerShareBasic_2_Q2_USD":1.77,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":8723000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":3646000.0,"Ticker":"UTMD","CIK":"706698","name":"UTAH MEDICAL PRODUCTS INC","OfficialName":"Utah Medical Products Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"319665163.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20210806"}]